Cite
MLA Citation
Sophie Cousin et al.. “Regorafenib–avelumab combination in patients with biliary tract cancer (REGOMUNE): a single-arm, open-label, phase II trial.” European journal of cancer, vol. 162, 2022, pp. 161–169. http://access.bl.uk/ark:/81055/vdc_100150528212.0x000023